Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-?B-inducing kinase while activating both canonical and alternative nuclear factor-?B pathways.
Ontology highlight
ABSTRACT: Aberrant nuclear factor ?B (NF-?B) signaling has been found to be of particular importance in diffuse, large B-cell lymphoma (DLBCL) cell survival and proliferation. Although the canonical NF-?B signaling pathway has been studied in some detail, activation of the alternative NF-?B pathway in DLBCL is not well characterized. Important insights into the regulation of the alternative NF-?B pathway in B lymphocytes has recently revealed the regulatory importance of the survival kinase NIK (NF-?B-inducing kinase) in genetically engineered murine models. Our studies demonstrate that both the canonical and alternative NF-?B pathways are constitutively activated in DLBCL. We also demonstrate that NIK kinase aberrantly accumulates in DLBCL cells due to constitutive activation of B-cell activation factor (BAFF)-R (BR3) through interaction with autochthonous B-lymphocyte stimulator (BLyS) ligand in DLBCL cells. Activation of BR3 in DLBCL induces recruitment and degradation of tumor necrosis factor receptor-associated factor 3, which results in NIK kinase accumulation, I?B? phosphorylation, and NF-?B p100 processing, thereby resulting in continuous activation of both NF-?B pathways in DLBCL cells, leading to autonomous lymphoma cell growth and survival. These results further elucidate mechanisms involved in abnormal NF-?B activation in DLBCL, and should contribute to better future therapeutic approaches for patients with DLBCL.
SUBMITTER: Pham LV
PROVIDER: S-EPMC3037744 | biostudies-literature | 2011 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA